FFA
DFTX

Farther Finance Advisors’s Definium Therapeutics DFTX Stock Holding History

Farther Finance Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.7K Buy
1,162
+595
+105% +$14.7K ﹤0.01% 3187
2026
Q1 		$11.7K Buy
567
+110
+24% +$1.87K ﹤0.01% 3999
2025
Q4 		$6.12K Hold
457
– – ﹤0.01% 4193
2025
Q3 		$5.39K Hold
457
– – ﹤0.01% 3727
2025
Q2 		$2.97K Sell
457
-537
-54% -$3.53K ﹤0.01% 3561
2025
Q1 		$5.51K Buy
994
+93
+10% +$666 ﹤0.01% 3012
2024
Q4 		$6.27K Sell
901
-20
-2% -$138 ﹤0.01% 2570
2024
Q3 		$5.24K Buy
921
+821
+821% +$5.71K ﹤0.01% 2627
2024
Q2 		$707 Hold
100
– – ﹤0.01% 3181
2024
Q1 		$952 Hold
100
– – ﹤0.01% 2799
2023
Q4 		$366 Hold
100
– – ﹤0.01% 3075
2023
Q3 		$313 Hold
100
– – ﹤0.01% 2372
2023
Q2 		$357 Hold
100
– – ﹤0.01% 2240
2023
Q1 		$317 Buy
+100
New +$332 ﹤0.01% 2111

Other funds holding DFTX

PFA
Peak Financial Advisors Denver, Colorado $242M AUM 19.63% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
BRG
Bay Rivers Group Williamsburg, Virginia $293M AUM 48.17% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $289M AUM 20.84% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's DFTX Position: Q2 2026 in Review

Farther Finance Advisors increased its Definium Therapeutics (DFTX) stake by 105% in Q2 2026, buying an estimated $14.7K and bringing the position to 1,162 shares worth $54.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3187.

Farther Finance Advisors first reported a position in DFTX in Q1 2023 and has held it in 14 quarters since. 17 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Farther Finance Advisors held 1,162 shares of Definium Therapeutics worth $54.7K as of Q2 2026.
  • Farther Finance Advisors bought 595 Definium Therapeutics shares in Q2 2026, an estimated $14.7K.
  • Definium Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3187 holding.
  • Farther Finance Advisors first reported a position in Definium Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • 17 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.